Athira Pharma, Inc.
ATHA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,611 | -$6,966 | -$9,143 | -$15,003 |
| Dep. & Amort. | $243 | $116 | $243 | $243 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1,597 | $1,637 | $2,229 |
| Change in WC | $291 | -$1,813 | -$7,402 | -$13,518 |
| Other Non-Cash | $1,409 | $67 | $0 | $36 |
| Operating Cash Flow | -$4,668 | -$6,999 | -$14,665 | -$26,013 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$3,336 | -$6,068 | -$10,201 | -$2,812 |
| Inv. Sales/Matur. | $8,990 | $6,509 | $2,850 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $5,654 | $441 | -$7,351 | -$2,812 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $34 |
| Stock Repurch. | $0 | $24 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $24 | $0 | $34 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $986 | -$6,534 | -$22,016 | -$28,791 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $19,888 | $27,053 | $49,069 | $77,860 |
| End Cash | $20,874 | $20,519 | $27,053 | $49,069 |
| Free Cash Flow | -$4,668 | -$6,999 | -$14,665 | -$26,013 |